Kewaunee Scientific Corporation (KEQU) Financial Statements (2025 and earlier)

Company Profile

Business Address 2700 W FRONT ST
STATESVILLE, NC 28677
State of Incorp. DE
Fiscal Year End April 30
Industry (SIC) 3821 - Laboratory Apparatus and Furniture (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
4/30/2024
Q4
1/31/2024
Q3
10/31/2023
Q2
7/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25,96324,21123,26721,31213,72212,699
Cash and cash equivalent25,96324,21123,26721,31213,72212,699
Restricted cash and investments3,7019752,6715,8007,9898,869
Receivables41,88543,54545,06441,10942,60042,461
Inventory, net of allowances, customer advances and progress billings18,65919,28520,67921,84521,66622,126
Inventory18,65919,28520,67921,84521,66622,126
Other undisclosed current assets6,2284,6835,1366,0904,8997,365
Total current assets:96,43692,69996,81796,15690,87693,520
Noncurrent Assets
Operating lease, right-of-use asset6,9416,9447,4547,8278,3938,612
Property, plant and equipment16,99017,11217,64917,49217,83417,339
Intangible assets, net (including goodwill)      
Goodwill      
Intangible assets, net (excluding goodwill)      
Deferred income tax assets8,3058,0917,401   
Other noncurrent assets5,8067,1725,4454,8304,6055,347
Total noncurrent assets:38,04239,31937,94930,14930,83231,298
TOTAL ASSETS:134,478132,018134,766126,305121,708124,818
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,45625,24830,36025,84925,03229,451
Accounts payable21,45820,61923,26219,08319,17222,140
Accrued liabilities4,9984,6297,0986,7665,8607,311
Deferred revenue6,2394,9374,37410,2484,9197,067
Debt1091133,21011010886
Other undisclosed current liabilities3,6676,3892,8365,9358,6737,625
Total current liabilities:36,47136,68740,78042,14238,73244,229
Noncurrent Liabilities
Long-term debt and lease obligation156222235247259143
Long-term debt, excluding current maturities      
Finance lease, liability156222235247259143
Liabilities, other than long-term debt6,5376,8467,1147,3167,6828,087
Deferred income tax liabilities1,0421,2731,2181,1341,051989
Other liabilities460462462441438453
Operating lease, liability5,0355,1115,4345,7416,1936,645
Other undisclosed noncurrent liabilities30,65730,75030,42831,25831,62131,819
Total noncurrent liabilities:37,35037,81837,77738,82139,56240,049
Total liabilities:73,82174,50578,55780,96378,29484,278
Equity
Equity, attributable to parent59,32856,02354,76044,08342,10839,430
Common stock7,3537,3537,2737,2707,2697,269
Treasury stock, value(2,051)(2,051)(2,051)(844)(97)(53)
Additional paid in capital4,8854,5125,4065,0464,8064,565
Accumulated other comprehensive loss(3,574)(3,498)(3,382)(3,877)(3,837)(3,586)
Retained earnings52,71549,70747,51436,48833,96731,235
Equity, attributable to noncontrolling interest1,3291,4901,4491,2591,3061,110
Total equity:60,65757,51356,20945,34243,41440,540
TOTAL LIABILITIES AND EQUITY:134,478132,018134,766126,305121,708124,818

Income Statement (P&L) ($ in thousands)

1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
4/30/2024
Q4
1/31/2024
Q3
10/31/2023
Q2
7/31/2023
Q1
Revenues47,76448,39356,70246,77850,43649,839
Cost of revenue
(Cost of Product and Service Sold)
(33,812)(35,905)(42,062)(34,749)(36,968)(37,925)
Gross profit:13,95212,48814,64012,02913,46811,914
Operating expenses(9,518)(9,913)(9,082)(8,223)(8,359)(8,106)
Operating income:4,4342,5755,5583,8065,1093,808
Interest and debt expense(442)(472)(586)(411)(372)(430)
Income from continuing operations before equity method investments, income taxes:3,9922,1034,9723,3954,7373,378
Other undisclosed income (loss) from continuing operations before income taxes(61)327(3,625)12010834
Income from continuing operations before income taxes:3,9312,4301,3473,5154,8453,412
Income tax expense (benefit)(916)(192)9,832(982)(2,015)(897)
Net income:3,0152,23811,1792,5332,8302,515
Net loss attributable to noncontrolling interest(7)(45)(153)(12)(98)(41)
Net income available to common stockholders, diluted:3,0082,19311,0262,5212,7322,474

Comprehensive Income ($ in thousands)

1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
4/30/2024
Q4
1/31/2024
Q3
10/31/2023
Q2
7/31/2023
Q1
Net income:3,0152,23811,1792,5332,8302,515
Other comprehensive income (loss)(76)(116)495(40)(251)(144)
Comprehensive income:2,9392,12211,6742,4932,5792,371
Comprehensive loss, net of tax, attributable to noncontrolling interest(7)(45)(153)(12)(98)(41)
Comprehensive income, net of tax, attributable to parent:2,9322,07711,5212,4812,4812,330

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: